Pharma Market Access Insights - from Petauri Evidence
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
Pharma Market Access Insights - from Petauri Evidence
Pharmacy, Medicines, and Specialised Commissioning in the new NHS
What changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? Professor Inderjit Singh (Chief Pharmacist at University Hospitals Birmingham) joins Tom Clarke (Director, Mtech Access) to explore all this and more.
Professor Singh is one of the leading pharmacists in today’s NHS and is currently Chief Pharmacist at University Hospitals Birmingham NHS Foundation Trust. He has responsibility for the provision of the pharmacy service within the Trust and for ensuring appropriate governance of medicines. He provides strategic oversight into commercial pharmacy matters and strategic support to Heath Trust Europe, a collaborative procurement hub based in Birmingham.
This episode was first broadcast as a live webinar on Friday 26th March 2021.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence